Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Strength in Numbers: EU Cross-Country Drug Pricing Coalitions Join Forces

Concerns Emerge Over Insufficient Data To Support Decision-Making

Executive Summary

Two groups of smaller European countries have agreed to collaborate on tackling challenges relating to accessing expensive new medicines.

You may also be interested in...



European Countries Should Join Forces To Lower Prices of Zolgensma & Kaftrio

The Dutch HTA institute is calling for hefty discounts of 50% and 75% for Novartis’s gene therapy and Vertex’s cystic fibrosis product.

International Horizon Scanning Initiative To Level Pricing Playing Field

Nine countries are joining forces on horizon scanning with the aim of improving their chances of securing lower prices for high-cost drugs.

Germany To Tackle Cell And Gene Therapy Funding Barriers

If approved, new legislation would allow hospitals to apply for funding for ATMPs before marketing authorization.

Topics

UsernamePublicRestriction

Register

PS144443

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel